The carmaker has followed up a $100m investment two years ago with a pledge to provide up to $200m for the Stanford-originated solid-state battery developer.

The protein degradation-focused drug developer, a spinout from Dana-Farber Cancer Institute, received $150m in series B funding and $20m in venture debt.

The carmaker has followed up a $100m investment two years ago with a pledge to provide up to $200m for the solid-state battery developer.

The Roche, Novartis and Kraft Group-backed, protein degradation-focused drug developer received $150m in series B funding and $20m in venture debt.

SK China, Xiaomi and Lenovo were among the investors as BYD's electric vehicle chip spinoff added $113m to the $265m it announced last month.

Continental Grain invested in a series D round that boosted the RNA technology provider's overall funding to $214m as it allocates more resources to vaccine work.

The Eli Lilly and Genmab-backed RNA drug developer is now valued at nearly $1.5bn following a decision to refocus on a coronavirus vaccine.

The Eli Lilly and Genmab-backed RNA drug developer is now valued at nearly $1.5bn following a decision to refocus on a coronavirus vaccine.

The Alibaba and Telstra-backed cloud services provider has secured series F funding in what is reportedly its third nine-figure round.

BCC, Broadway Video, WME and Chernin Group were reportedly among the investors that added $47.7m to the $93m in financing the meditation platform raised in February.